艾德韋宣集團(09919.HK)附屬與廣州悦跑就擬合作開發營運APP訂立諒解備忘錄
格隆匯6月2日丨艾德韋宣集團(09919.HK)發佈公告,2020年6月2日,公司間接非全資附屬公司艾德韋宣體育與廣州悦跑信息科技有限公司就可能合作開發和營運新在線運動自行車流動應用程式(“APP”)訂立諒解備忘錄。
根據諒解備忘錄,訂約方同意(其中包括)以下合作意向:1.訂約雙方同意於上海成立合營企業,建議合營企業由艾德韋宣體育及廣州悦跑分別擁有51%及49%;2.艾德韋宣體育會將自有資源與APP結合,包括但不限於在中國提供相關競賽資源;及在中國憑藉“環法自行車賽”的知識產權推廣體育文化;3.廣州悦跑負責進行APP的研究及開發;申請APP在中國的註冊;及促進APP的流量。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.